Table 1C).
NA cells treated with ciglitazone, percentage of cells in each cell cycle phase in duplicate assays
| Condition (μM) |
G1 | S | G2 | |||
|---|---|---|---|---|---|---|
| Control | 89.2 | 89.2 | 9.4 | 9.4 | 1.5 | 1.5 |
| C5 | 79.4 | 86.7 | 18 | 12.5 | 2.7 | 0.81 |
| C10 | 80.6 | 84.9 | 15.1 | 10 | 4.4 | 5.1 |
NA cells treated with ciglitazone, percentage of cells in each cell cycle phase in duplicate assays
| Condition (μM) |
G1 | S | G2 | |||
|---|---|---|---|---|---|---|
| Control | 89.2 | 89.2 | 9.4 | 9.4 | 1.5 | 1.5 |
| C5 | 79.4 | 86.7 | 18 | 12.5 | 2.7 | 0.81 |
| C10 | 80.6 | 84.9 | 15.1 | 10 | 4.4 | 5.1 |